Market data not licensed for redistribution.
Kyongbo Pharmaceutical
214390 ยท KOSPI ยท Manufacture of Basic Pharmaceutical Products
Close
Source: Financial Services Commission stock price data (data.go.kr), updated once a day.
Daily price, 1 year
Key statistics
Market cap (KRW bn)โ
PERโ
PBRโ
ROE %3.4
Debt ratio % (liabilities / equity)150
Revenue TTM (KRW bn)279.6
Op. profit TTM (KRW bn)2.6
Dividend yield %โ
Basis: market cap at โฆ; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (separate). PER is not shown when TTM net income is negative.
Upcoming risk events
Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.
No scheduled risk events found (last checked 2026-10-30 19:40 KST).
Annual results (KRW bn)
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | 170.7 | 196.3 | 216.4 | 238.6 | 264.1 |
| Operating profit | -6.6 | 1.4 | 5.5 | 10.5 | 3.5 |
| Net income | -7.5 | 0.6 | 3.0 | 4.6 | 0.2 |
Quarterly results (KRW bn, 3 months)
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | |
|---|---|---|---|---|---|---|
| Revenue | 60.6 | 65.3 | 67.0 | 71.2 | 66.1 | 75.2 |
| Operating profit | 0.1 | 2.4 | 0.5 | 0.5 | 0.7 | 0.9 |
| Net income | -0.7 | -1.7 | 3.0 | -0.4 | -0.5 | 3.0 |
Largest shareholder
As of the 2025 annual report: (์ฃผ)์ข ๊ทผ๋นํ๋ฉ์ค and related parties hold 60.56% of common shares.
Recent disclosures
| Date | Filing | Summary | |
|---|---|---|---|
| 2026-10-30 | Preliminary earnings ์์ (์ ์ )์ค์ (๊ณต์ ๊ณต์) | DART original | |
| 2026-09-30 | Business / production suspension [๊ธฐ์ฌ์ ์ ]์ฃผ์์ฌํญ๋ณด๊ณ ์(์์ ์ ์ง) | DART original | |
| 2026-08-31 | Business / production suspension [๊ธฐ์ฌ์ ์ ]์ฃผ์์ฌํญ๋ณด๊ณ ์(์์ ์ ์ง) | DART original | |
| 2026-08-14 | Periodic report (annual/half/quarterly) ๋ฐ๊ธฐ๋ณด๊ณ ์ (2026.06) | DART original | |
| 2026-07-31 | Preliminary earnings ์์ (์ ์ )์ค์ (๊ณต์ ๊ณต์) | DART original | |
| 2026-06-26 | Other ์ง์๊ฐ๋ฅ๊ฒฝ์๋ณด๊ณ ์๋ฑ๊ด๋ จ์ฌํญ(์์จ๊ณต์) | DART original | |
| 2026-06-01 | Governance / misc. (routine) ๊ธฐ์ ์ง๋ฐฐ๊ตฌ์กฐ๋ณด๊ณ ์๊ณต์ | DART original | |
| 2026-05-15 | Periodic report (annual/half/quarterly) ๋ถ๊ธฐ๋ณด๊ณ ์ (2026.03) | DART original | |
| 2026-04-29 | Preliminary earnings ์์ (์ ์ )์ค์ (๊ณต์ ๊ณต์) | DART original | |
| 2026-04-10 | Supply contract termination ๋จ์ผํ๋งคใ๊ณต๊ธ๊ณ์ฝํด์ง | DART original | |
| 2026-03-26 | Corporate value-up plan ๊ธฐ์ ๊ฐ์น์ ๊ณ ๊ณํ(์์จ๊ณต์) | DART original | |
| 2026-03-26 | Shareholder meeting ์ ๊ธฐ์ฃผ์ฃผ์ดํ๊ฒฐ๊ณผ | DART original |
Past material filings and price reaction (market-adjusted)
| Date | Filing type | On the news (vs. market) | Next day (vs. market) | 20 days (vs. market) |
|---|---|---|---|---|
| 2026-07-31 | Preliminary earnings | +2.8% | +3.0% | +0.7% |
| 2026-04-29 | Preliminary earnings | -0.9% | +0.5% | -49.0% |
| 2026-04-10 | Supply contract termination | -0.0% | +1.3% | -42.2% |
| 2026-03-26 | Corporate value-up plan | +1.8% | -1.6% | -36.6% |
| 2026-02-24 | Cash/stock dividend decision | -0.9% | -1.7% | +48.1% |
| 2026-02-02 | Revenue/profit change >=30% (15% large caps) | -3.0% | -3.6% | -14.5% |
| 2025-10-31 | Preliminary earnings | -0.4% | -2.2% | +7.1% |
| 2025-07-25 | Preliminary earnings | -1.2% | +0.6% | -3.2% |
| 2025-06-12 | Business / production suspension | -2.2% | -4.0% | -13.5% |
| 2025-06-12 | Trading halt | -2.2% | -4.0% | -13.5% |
For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer โ Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
ยฉ Crypvu ยท Crypto market view
Market data not licensed for redistribution.
ยฉ Crypvu ยท Crypto market view